Pharmacy News

Hospira Recalls Dextrose with Lactated Ringer Injection, Expands Heparin Recall

Cheryl A. Thompson

BETHESDA, MD 11 Jul 2014—Hospira Inc. on Thursday announced the recall of lot 35-118-JT of the company's 1000-mL 5% dextrose with lactated Ringer injection (PDF)External Link because a filamentous particulate in the solution of one primary container looked like mold. This primary container had a puncture in the same location as a puncture found in the overwrap, which, the company said, caused the primary container to leak and could have created the opportunity for contamination.

Containers in this lot were distributed December 2013 through February 2014 to hospitals, clinics, wholesalers, and distributors.

On June 30, the company announced expansion of the June 6 recall of 250-mL heparin sodium in 5% dextrose injection (PDF)External Link, 100 units/mL. The original recall pertained to lots 34-811-KL, 36-106-KL, and 36-114-KL, distributed February through April 2014. Last week's expansion adds lots 36-101-KL, 37-202-KL, 38-302-KL, and 38-305-KL, distributed January through May 2014.

Containers in these seven heparin lots may leak at or near the administrative port, the company said.

Stericycle is handling these recalls and is available from 8 a.m. to 5 p.m. EST Monday through Friday. Hospira's notice about the recall of 5% dextrose with lactated Ringer injection directs customers to call Stericycle at 888-912-8457. The notice about the original recall of heparin sodium in 5% dextrose injection tells customers to call 888-345-3842. And the notice about the expanded heparin recall says to call 888-462-0579.

Hospira said questions about the availability of replacement heparin product should be directed to the company's customer care group at 877-946-7747, available 7 a.m. to 6 p.m. CT Monday through Friday. Or customers may contact their Hospira representative.


Contact Us
For questions, comments, or more information on this article, please contact the ASHP News Center at
ASHP Product Listing